« BIO v. DC and the New Need to Eliminate Federal Patent Law Preemption of State and Local Price and Product Regulation | Main | Reestablishing the Doctrine of Patent Exhaustion »

November 04, 2007

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8341c588553ef00e54f79abde8833

Listed below are links to weblogs that reference The GSK Case: An Administrative Perspective:

Comments

The comments to this entry are closed.